Emergency Department (ED)-Directed Interventions to Improve Asthma Outcomes

Summary

The purpose of this study is to determine if evidence-based guidance on follow-up care and self-management provided to PCPs and patients, respectively, reduces relapses within 90 days for acute asthma (primary outcome). Secondary outcomes will include follow-up visits with the primary care provider, patients' quality of life and cost-effectiveness indicators.

Conditions

• Acute Asthma

Interventions

BEHAVIORAL

Opinion Leader letter

The patients' PCP will be notified by fax about the ED visit and management. The Opinion Leader letter will contain a summary of the current asthma guidelines for ambulatory care (including: asthma education, long-term recommendations, smoking cessation, and action plan) signed by a local opinion leader. A review of the patient's management within a week of the ED visit will be recommended. The patient will also receive information regarding their acute exacerbation and will be told to review the current management of their disease with their PCP.

BEHAVIORAL

Involvement of a care manager

The involvement of a care manager will encourage patients' to pursue follow-up, provide management review and offer brief education via telephone within a week of being discharged

BEHAVIORAL

Usual care

Usual care provided to asthma patients when discharged from the ED

Sponsors & Collaborators

• University of Alberta

  lead OTHER

Principal Investigators

• Brian H Rowe, MD, MSc · University of Alberta

• Cristina Villa-Roel, MD, MSc · University of Alberta

• Eddy Lang, MD · University of Calgary

• Mohit Bhutani, MD · University of Alberta

• Bjug Borgundvaag, MD · University of Toronto

• Richard Leigh, MD · University of Calgary

• Sumit Majumdar, MD, MSc · University of Alberta

• Christopher McCabe, PhD · University of Alberta

• Rhonda Rosychuk, PhD · University of Alberta

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

17 Years

Max Age

55 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2012-06-30

Primary Completion

2016-03-31

Completion

2016-03-31

Countries

• Canada

Study Locations